Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

T&T Trial: Adding Testosterone to Tamoxifen in Male Breast Cancer Patients

NCT05156606 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT05156606
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05156606 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
T&T Trial: Adding Testosterone to Tamoxifen in Male Breast Cancer Patients
Lead sponsor
University Medical Center Groningen
Phase
Not applicable
Overall status
Terminated
Start date
November 10, 2022
Completion date
July 31, 2024
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

male breast cancer